Passage BIO PASG
NASDAQ PASG
$4.12 -0.20 (-4.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Passage BIO (PASG) Sales of Property, Plant and Equipment (2025 - 2026)

Updated

Passage BIO (PASG) posted Sales of Property, Plant and Equipment of $20,000 for Q1 2026, down 96.6% from $585,000 a year earlier.

Analysis

Passage BIO (PASG) Sales of Property, Plant and Equipment (2025 - 2026) Analysis & Trends

For FY2025, Passage BIO's Sales of Property, Plant and Equipment came in at $1.17 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Passage BIO 13.26 Mn 13.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 20,000.00
Jun 30, 2025 585,000.00
Mar 31, 2025 585,000.00
API Access

Passage BIO Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=PASG&period=max&api_key=YOUR_API_KEY